Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [T6] Chauhan - ETCTN 10450: a Phase 1 Trial of Peposertib and Lutetium Lu 177 Dotatate in Well-differentiated Somatostatin Receptor Published in 2021 Listed under Poster Download [T5] Chauhan - ETCTN 10388: a Phase 1 Trial of Triapine and Lutetium 177 Dotatate in Well-differentiated Somatostatin Receptorpositive Gastroenteropancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [T4] O'Dorisio - A Phase II Trial to Evaluate the Safety and Dosimetry of [177Lu]Lu-DOTA-TATE in Adolescent Patients with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP Published in 2021 Listed under Poster Download [T3] Singh - [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): the NETTER-2 Study Published in 2021 Listed under Poster Download [T2] Lagast - Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of Patients with Carcinoid Syndrome (CS) Published in 2021 Listed under Poster Download [T1] El-Rayes - Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P9] Mulvey - The Impact of Sociodemographic Factors on Overall Survival for Patients with Adrenocortical Carcinomas in California Published in 2021 Listed under Poster Download [P8] Harsha Tella - Association Between Hospital Volume and Overall Survival of Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P7] Lee - Prevalence and Presentation of Cushing and Carcinoid Syndromes in Patients with Non-metastatic Primary Lung Published in 2021 Listed under Poster Download [P6] Zarate Rodriguez - Surgical Interventions in Patients with Pancreatic Neuroendocrine Tumors: a SEER-based Survival Analysis Published in 2021 Listed under Poster Download [P5] Zarate Rodriguez - Race is an Independent Predictor for Surgery Offer in Patients with Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P4] Bateni - Secondary Primary Cancers and Survival among Neuroendocrine Tumor Patients Published in 2021 Listed under Poster Download [P3] Bateni - Incidence and Predictors of Second Cancers in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P2] Hallet - Incidence of Psychiatric Illness in Patients With Neuroendocrine Tumors - A Comparative Population-Based Published in 2021 Listed under Poster Download [P1] Wong - Predictors And Outcomes Of Minimally Invasive Surgery For Small Bowel Neuroendocrine Tumors Published in 2021 Listed under Poster Download [P12] Albor - MDT Experience in Argentina in Nets in Times of the Covid19 Pandemic Published in 2021 Listed under Poster Download [P11] Abdelrahman - The Epidemiology of Mixed Acinar Neuroendocrine Carcinoma of the Pancreas in the United States Published in 2021 Listed under Poster Download [P10] Rakshit - Covid-19 in Patients with Neuroendocrine Tumors (NETs): the Mayo Clinic Experience Published in 2021 Listed under Poster Download [O8] Anaka - Understanding Neuroendocrine Tumour Patient Preferences for Medical Management of Midgut NETs Using Discrete Choice Experiments: a DIRECT NETs Study Published in 2021 Listed under Poster Download [O7] Wachtel - Succinate Dehydrogenase Pathogenic Variants are Not Associated with Non-canonical Cancers Published in 2021 Listed under Poster Download [O6] Tsang - Evaluating the Association Between Family History and Overall Survival Among Patients with Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [O5] Hickman - Outcomes of Initial Treatment in Early Stage Neuroendocrine Carcinoma of the Uterine Cervix (NCUC) Published in 2021 Listed under Poster Download [O4] Kolarova - Neuroendocrine Tumor Treatments and Follow-up Disease Management - Comparative Perspective (U.S. and Canada Published in 2021 Listed under Poster Download [O3] Hallet - Patient-reported Cognitive and Psychological Screening in Neuroendocrine Tumors (NETs) - a Prospective Cohort Published in 2021 Listed under Poster Download [O2] Yen - The Feasibility and Acceptability of Health and Wellness Coaching for Neuroendocrine Tumor Patients and Their Published in 2021 Listed under Poster Download [O1] Das - A Systematic Survey of Two Decades of Clinical Trials in Neuroendocrine Neoplasms (NENs) Published in 2021 Listed under Poster Download [C9] Siddiqui - Real World Use of Lanreotide in Management of Neuroendocrine Tumours Published in 2021 Listed under Poster Download [C8] Reidy-Lagunes - Lanreotide Autogel/Depot (LAN) in Patients with Advanced Bronchopulmonary (BP) Neuroendocrine Tumors (NETs): Results From the Phase 3 SPINET Study Published in 2021 Listed under Poster Download [C7] Halperin - The Safety and Efficacy of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate in Patients (Pts) with Advanced GI Mid-gut Neuroendocrine Tumor (NET): Phase 2 Results Published in 2021 Listed under Poster Download [C6] Guo - Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C5] Li - Interim analysis results of surufatinib in US patients with neuroendocrine tumors (NETs) Published in 2021 Listed under Poster Download [C57] Chauhan - HPG80 (circulating progastrin), a Novel Blood-based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Published in 2021 Listed under Poster Download [C56] DiPeri - Comparison of Patients with Small Bowel Neuroendocrine Tumor Liver Metastaseswith and without Carcinoid Syndrome: A Single Institutional Analysis Published in 2021 Listed under Poster Download [C55] Pulvirenti - Early Onset Well Differentiated Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathologic Features, and Published in 2021 Listed under Poster Download [C54] Herring - Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors from Black and White Published in 2021 Listed under Poster Download [C53] Pommier - A Prospective Study of Carcinoid Crisis with No Perioperative Octreotide Published in 2021 Listed under Poster Download [C52] Nguyen - Role of Chromogranin A in the Diagnosis and Follow up of Neuroendocrine Neoplasms: Real World Review Published in 2021 Listed under Poster Download [C51] Naaseh - A Single-Center Experience in Observation of Small Pancreatic Neuroendocrine Tumors: To Operate or Not to Published in 2021 Listed under Poster Download [C50] Slattery - Detection Method and Overall Survival in Surgically Resected Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C4] Littlejohn - An Open-Label, Phase II Investigation of Trifluridine/Tipiracil in Patients With High-Grade, Extrapulmonary Published in 2021 Download [C49] Watanabe - Importance of Grade in the Surgical Management of Rectal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C48] Shi - Venous Invasion in Resected Pancreatic Neuroendocrine Tumors Is Independently Associated with Disease Free Published in 2021 Listed under Poster Download [C47] Shi - Pathologic Features of Small Pancreatic Neuroendocrine Tumors with Liver Metastasis Published in 2021 Listed under Poster Download [C46] Gudmundsdottir - Alternative Lengthening of Telomeres Is Associated with Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C45] Tran - Management of Duodenal Neuroendocrine Tumors: Surgical Versus Endoscopic Mucosal Resection Published in 2021 Listed under Poster Download [C44] Gudmundsdottir - Multifocality Is Not Associated with Worse Survival in Sporadic Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C43] Malhotra - MRI Has Improved Detection of Small Neuroendocrine Liver Metastasis Compared with Ga-68 DOTATATE Published in 2021 Listed under Poster Download [C42] Zan - A Case of G3-WD Gastric Carcinoid Tumor in a MEN1 Patient with Discrepant Treatment Response to PRRT in Published in 2021 Listed under Poster Download [C41] Gupta - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy [Evero-Embo] in Patients with Bulky and/or Progressive Metastatic Well Differentiated Neuroendocrine Published in 2021 Listed under Poster Download [C40] Gococo-Benore - Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients Published in 2021 Listed under Poster Download [C3] Li - Patient-reported Clinical and Productivity Outcomes From the Longitudinal Telotristat Ethyl Treatment Registry Published in 2021 Listed under Poster Download [C39] Bodei - Blood-based Genomic Assessment of Clinical Efficacy and Toxicity of 177Lu-DOTATATE of Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C38] Lawhn-Heath - Clinical Utility of Qualitative Post-treatment SPECT After Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C37] Coffman - Treatment Response and Clinical Outcomes of Well-differentiated (WD) High-grade (HG) Neuroendocrine Tumors (NETs) to 177Lu-DOTATATE Published in 2021 Listed under Poster Download [C36] Soulen - Cap-Tem-Y90 for Grade 2 Liver-dominant Net Metastases Published in 2021 Listed under Poster Download [C35] Manohar - 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: a Single Center Experience Published in 2021 Listed under Poster Download [C34] Pryma - Secondary Hematological Malignancies Following Highspecific Activity Iodine-131 Metaiodobenzylguanidine Treatment of Advanced Pheochromocytoma and Published in 2021 Listed under Poster Download [C33] Norman - Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine Published in 2021 Listed under Poster Download [C32] Kunz - The Phase 3 NETTER-1 Study of 177Lu-DOTATATE in Patients with Midgut Neuroendocrine Tumors: Updated Published in 2021 Listed under Poster Download [C31] Grønbæk - Safety and Effectiveness of 177Lu-Satoreotide Tetraxetan in Patients with Progressive Neuroendocrine Tumors (NETs): Interim Analysis of a Phase I/II Study Published in 2021 Listed under Poster Download [C30] Halfdanarson - Compose: Pivotal Phase III Trial of 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade 2 and Grade 3 Gastroenteropancreatic Published in 2021 Listed under Poster Download [C2] Mohamed - The Role of Microbiome in Gastroentero-pancreatic Neuroendocrine Neoplasms (GEP-NENs) Published in 2021 Listed under Poster Download [C29] Clement - Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Advanced Pancreatic Neuroendocrine Tumours (panNETs): Data From the NETTER-R International, Published in 2021 Listed under Poster Download [C28] Yu - Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Pancreatic Published in 2021 Listed under Poster Download [C27] Zhou - Subgroup Analysis by Ki-67 and Primary Tumor Origins of the Randomized, Placebo-controlled Phase 3 Study of Surufatinib in Advanced Well-differentiated Extrapancreatic Neuroendocrine Tumors (SANET-ep) Published in 2021 Listed under Poster Download [C26] Duan - Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Published in 2021 Listed under Poster Download [C25] Weekley - Comparing Periprocedural Hemodynamic Instability in Y-90 Radioembolization and Bland Embolization for Neuroendocrine Tumor Liver Metastases Published in 2021 Listed under Poster Download [C24] Badawy - Peptide Receptor Radionuclide Therapy (Lu-177 DOTATATE) in Progressive Neuroendocrine Tumors (NETs): Potential Predictors of Progression Free Survival (PFS) Published in 2021 Listed under Poster Download [C23] Wong - Long-term Outcomes Following 90YRadioembolization of Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C22] Attiyeh - Defining MRI Superiority Over CT for Neuroendocrine Liver Metastases Published in 2021 Listed under Poster Download [C21] Das - Validation of a Clinical Score (CS) for Patients With WellDifferentiated Neuroendocrine Tumors (WD NETs) Under Consideration for Peptide Receptor Radionuclide Therapy Published in 2021 Listed under Poster Download [C20] Raj - Randomized Blinded Study Comparing Injection Site Pain From Octreotide Long-acting-release (LAR) Versus Lanreotide During the Treatment of Well-differentiated Published in 2021 Listed under Poster Download [C1] Gile - Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy in Patients with High-grade Extrapulmonary Published in 2021 Listed under Poster Download [C19] Chan - Phase 2 Trial of Pembrolizumab-based Therapy in Previously Treated Extrapulmonary Poorly-differentiated Neuroendocrine Carcinomas: Results of Part B Published in 2021 Listed under Poster Download [C18] Shen - A Phase 2 Study of Surufatinib in Combination with Toripalimab in Patients with Advanced Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C17] Hauser - Treatment Response and Clinical Outcomes of Neuroendocrine Neoplasms (NENs) Treated with Immune Checkpoint Inhibitors (ICIs): a Single Institution Experience Published in 2021 Listed under Poster Download [C16] Al-Toubah - Efficacy of Ipilimumab and Nivolumab in Patients with Highgrade Neuroendocrine Neoplasms Published in 2021 Listed under Poster Download [C15] Al-Toubah - Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors Published in 2021 Listed under Poster Download [C14] Mohamed - Exploring Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [C13] Bai - Health-related Quality-of-life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep) Published in 2021 Listed under Poster Download [C12] Khuong Le - Urinary Neuroendocrine Neoplasms (NENs) Treated in the "Modern Era": A Multicenter Retrospective Review Published in 2021 Listed under Poster Download [C11] Desai - Lurbinectedin in Extrapulmonary Metastatic Neuroendocrine Carcinomas Published in 2021 Listed under Poster Download [C10] McGarrah - Genomic Profiling of Responders and Non-responders to Checkpoint Inhibition in Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [B9] Whitt - Natural Compound Verrucarin A Potentiates the Anticancer Effect of Etoposide in NET Cell Lines Published in 2021 Listed under Poster Download [B8] Tow - Development of a Real-time Luminescent Sensor for Detecting Serotonin Levels in Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B7] Armstrong - Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-like Pheochromocytomas Published in 2021 Listed under Poster Download [B6] Ear - Inhibition of Serotonin Biosynthesis Suppresses Tumor Published in 2021 Listed under Poster Download [B5] Shaikamjad - RABL6A-Myc Signaling Promotes Pancreatic Neuroendocrine Tumor Cell Proliferation and Survival Published in 2021 Listed under Poster Download [B4] Keutgen - Loss of MEN1 Function Inhibits DNA Repair Capability of Pancreatic Neuroendocrine Tumors after Radiation Published in 2021 Listed under Poster Download [B3] Guo - Cd36 Mediated Metabolic Reprogramming in Cancer Stem Cells Contributes to Drug Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B2] Tran - RNA-sequencing Identifies Unique Molecular Features of Duodenal Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B1] Ivanov - Sex-specific Transcriptional Differences and Loss of Gene Imprinting in Pancreatic Neuroendocrine Tumors Published in 2021 Listed under Poster Download [B17] Liu - Pre-clinical Evaluation of Alpha-particle Radiotherapy Targeting CXCR4 in Small Cell Lung Cancer Published in 2021 Listed under Poster Download [B16] Chauhan - Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma Published in 2021 Listed under Poster Download [B15] Tran - Comparison of Drug Sensitivity Profiles of Various NEN Spheroids Published in 2021 Listed under Poster Download [B14] Beyer - Establishment of Two Patient-derived Neuroendocrine Carcinoma Spheroid and Xenograft Models for Drug Testing Published in 2021 Download [B13] Jacenik - The MAP Kinase-activated Protein Kinase 2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Involving Action Mediated by Published in 2021 Listed under Poster Download [B12] Keutgen - Sunitinib-loaded Chondroitin Sulfate Hydrogels as a Novel Drug-delivery Mechanism for the Treatment of Pancreatic Published in 2021 Listed under Poster Download [B11] Guenter - Variability of Somatostatin Receptor Type 2 Immunohistochemical Staining Patterns Among Published in 2021 Listed under Poster Download [B10] Haas - Novel Fusion Gene UBTF-MAML3 Drives Tumorigenesis in Neuroendocrine Tumor Cells Published in 2021 Listed under Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
